End-of-day quote
Taipei Exchange
03:30:00 10/05/2024 am IST
|
5-day change
|
1st Jan Change
|
242.5
TWD
|
-0.61%
|
|
-12.14%
|
+25.97%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
977.7
|
4,371
|
4,700
|
5,262
|
8,292
|
Enterprise Value (EV)
1 |
1,090
|
4,537
|
4,963
|
5,135
|
8,383
|
P/E ratio
|
137
x
|
84.1
x
|
68.9
x
|
23.8
x
|
69.7
x
|
Yield
|
0.06%
|
0.55%
|
1.15%
|
3.16%
|
1.82%
|
Capitalization / Revenue
|
1.91
x
|
8.19
x
|
6.71
x
|
4.84
x
|
10.2
x
|
EV / Revenue
|
2.13
x
|
8.5
x
|
7.09
x
|
4.73
x
|
10.3
x
|
EV / EBITDA
|
17.9
x
|
32.9
x
|
29.3
x
|
14.3
x
|
39.3
x
|
EV / FCF
|
20.6
x
|
-61.2
x
|
-22.9
x
|
336
x
|
-86.7
x
|
FCF Yield
|
4.85%
|
-1.63%
|
-4.36%
|
0.3%
|
-1.15%
|
Price to Book
|
2.48
x
|
9.79
x
|
7.67
x
|
4.56
x
|
4.94
x
|
Nbr of stocks (in thousands)
|
33,139
|
33,139
|
34,463
|
38,773
|
43,073
|
Reference price
2 |
29.50
|
131.9
|
136.4
|
135.7
|
192.5
|
Announcement Date
|
24/04/20
|
13/04/21
|
16/03/22
|
14/03/23
|
14/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
520.3
|
512
|
533.5
|
700.4
|
1,087
|
815.2
|
EBITDA
1 |
27.16
|
60.91
|
137.9
|
169.5
|
358.3
|
213.5
|
EBIT
1 |
11.14
|
38.14
|
108.6
|
136.6
|
318.6
|
162.1
|
Operating Margin
|
2.14%
|
7.45%
|
20.36%
|
19.5%
|
29.32%
|
19.88%
|
Earnings before Tax (EBT)
1 |
10.16
|
33.76
|
106.1
|
134.5
|
332.2
|
162.2
|
Net income
1 |
3.97
|
6.71
|
51.97
|
67.76
|
215
|
108.3
|
Net margin
|
0.76%
|
1.31%
|
9.74%
|
9.68%
|
19.79%
|
13.29%
|
EPS
2 |
0.1308
|
0.2146
|
1.568
|
1.979
|
5.705
|
2.760
|
Free Cash Flow
1 |
-146
|
52.88
|
-74.17
|
-216.3
|
15.3
|
-96.67
|
FCF margin
|
-28.06%
|
10.33%
|
-13.9%
|
-30.89%
|
1.41%
|
-11.86%
|
FCF Conversion (EBITDA)
|
-
|
86.82%
|
-
|
-
|
4.27%
|
-
|
FCF Conversion (Net income)
|
-
|
788.06%
|
-
|
-
|
7.12%
|
-
|
Dividend per Share
2 |
0.1252
|
0.0179
|
0.7252
|
1.572
|
4.286
|
3.500
|
Announcement Date
|
30/04/19
|
24/04/20
|
13/04/21
|
16/03/22
|
14/03/23
|
14/03/24
|
Fiscal Period: December |
2022 Q1
|
2022 Q2
|
---|
Net sales
1 |
186.4
|
230.7
|
EBITDA
|
-
|
-
|
EBIT
1 |
33.97
|
62.79
|
Operating Margin
|
18.22%
|
27.21%
|
Earnings before Tax (EBT)
|
-
|
-
|
Net income
1 |
12.94
|
39.86
|
Net margin
|
6.94%
|
17.27%
|
EPS
2 |
0.3791
|
1.045
|
Dividend per Share
|
-
|
-
|
Announcement Date
|
12/05/22
|
12/08/22
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
229
|
113
|
166
|
263
|
-
|
91.1
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
127
|
-
|
Leverage (Debt/EBITDA)
|
8.449
x
|
1.847
x
|
1.203
x
|
1.552
x
|
-
|
0.4268
x
|
Free Cash Flow
1 |
-146
|
52.9
|
-74.2
|
-216
|
15.3
|
-96.7
|
ROE (net income / shareholders' equity)
|
2.04%
|
5.73%
|
16.1%
|
16.4%
|
25.1%
|
7.37%
|
ROA (Net income/ Total Assets)
|
0.98%
|
3.23%
|
8.26%
|
7.5%
|
12.6%
|
4.88%
|
Assets
1 |
404
|
207.5
|
629.5
|
904
|
1,700
|
2,218
|
Book Value Per Share
2 |
10.60
|
11.90
|
13.50
|
17.80
|
29.70
|
38.90
|
Cash Flow per Share
2 |
2.090
|
2.980
|
4.080
|
7.670
|
10.90
|
7.440
|
Capex
1 |
114
|
31.2
|
112
|
216
|
257
|
255
|
Capex / Sales
|
21.94%
|
6.1%
|
21%
|
30.78%
|
23.62%
|
31.24%
|
Announcement Date
|
30/04/19
|
24/04/20
|
13/04/21
|
16/03/22
|
14/03/23
|
14/03/24
|
|
1st Jan change
|
Capi.
|
---|
| +25.97% | 322M | | +17.73% | 66.69B | | +1.61% | 49.2B | | +16.33% | 41.24B | | +18.68% | 25.89B | | +12.78% | 19.81B | | -21.87% | 15.86B | | -10.29% | 15.23B | | +2.32% | 15.35B | | -22.30% | 13.36B |
Other Specialty Chemicals
|